fluorodeoxyglucose f18 has been researched along with Optic Neuropathy, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Both, M; Gross, WL; Heller, M; Moosig, F; Nölle, B; von Forstner, C | 1 |
| Bose, S; Fallon, JH; Mok, AC; Potkin, SG | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Optic Neuropathy, Ischemic
| Article | Year |
|---|---|
[Imaging techniques in the evaluation of primary large vessel vasculitides: Part 2: duplex ultrasound, positron emission tomography, computed tomography, and ophthalmological methods].
Topics: Angiography; Aortic Aneurysm; Aortic Dissection; Arterial Occlusive Diseases; Cone-Beam Computed Tomography; Diagnostic Techniques, Ophthalmological; Emergencies; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Optic Neuropathy, Ischemic; Positron-Emission Tomography; Retinal Artery Occlusion; Sensitivity and Specificity; Takayasu Arteritis; Tomography, X-Ray Computed; Ultrasonography, Doppler, Duplex | 2009 |
1 other study(ies) available for fluorodeoxyglucose f18 and Optic Neuropathy, Ischemic
| Article | Year |
|---|---|
Three-month change in cerebral glucose metabolism in patients with nonarteritic ischemic optic neuropathy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arteritis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Optic Neuropathy, Ischemic; Pentoxifylline; Positron-Emission Tomography; Radiopharmaceuticals; Vasodilator Agents; Visual Cortex | 2006 |